← Back to Search

Observational (interview, discussion) for Cancer

N/A
Waitlist Available
Led By Robert J Volk
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Summary

This study better understands the views on shared decision-making among Chinese adults who smoke or who have a spouse who smokes. Lung cancer is the second most common cancer among men and women in the United States and is the number one cause of cancer-related mortality among Asians and Pacific Islanders. Clinicians are recommended to initiate conversations about lung cancer screening with eligible patients, provide information about the benefits and harms, and engage in shared decision-making. However, a patient's cultural background can influence decision-making in many ways. Given this, there is a need to understand the perceptions of shared decision-making among different populations (in this case, Asian populations) in order to inform the design of culturally sensitive decision aids for cancer screening. This study evaluates how Chinese populations in the U.S. who currently smoke or who have partners who smoke perceive the process of shared decision-making, their preferences, the perceived barriers and facilitators, and their perspective on currently-available screening tools.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Chinese populations' preferences in terms of role involvement, and the barriers to and facilitators of shared decision-making
Current publicly available lung cancer screening tools from the perspective of Chinese adults who smoke or who have partners who smoke
How Chinese populations who smoke or have partners who smoke perceive the process of shared health-related decision-making

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (interview, discussion)Experimental Treatment2 Interventions
Participants attend an interview over 45-60 minutes and/or a focus group over 1.5 to 2 hours.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Discussion
2021
N/A
~180

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,039 Previous Clinical Trials
1,799,701 Total Patients Enrolled
Robert J VolkPrincipal InvestigatorM.D. Anderson Cancer Center
2 Previous Clinical Trials
1,320 Total Patients Enrolled
~0 spots leftby Sep 2025